<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/98394D9D-F27A-4D51-8500-8A03A6735AF1"><gtr:id>98394D9D-F27A-4D51-8500-8A03A6735AF1</gtr:id><gtr:name>Umea University</gtr:name><gtr:address><gtr:line1>Umea University</gtr:line1><gtr:postCode>SE-901 87</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Molecular Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/98394D9D-F27A-4D51-8500-8A03A6735AF1"><gtr:id>98394D9D-F27A-4D51-8500-8A03A6735AF1</gtr:id><gtr:name>Umea University</gtr:name><gtr:address><gtr:line1>Umea University</gtr:line1><gtr:postCode>SE-901 87</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/719BAA92-CA8A-435C-A068-835D6F1FAAE7"><gtr:id>719BAA92-CA8A-435C-A068-835D6F1FAAE7</gtr:id><gtr:firstName>Jafar</gtr:firstName><gtr:surname>Mahdavi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6193783C-53EE-49CE-BD1B-0C41A6F978ED"><gtr:id>6193783C-53EE-49CE-BD1B-0C41A6F978ED</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Hill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/35D2EF74-8DE0-407F-AB06-37D7FD42DEA9"><gtr:id>35D2EF74-8DE0-407F-AB06-37D7FD42DEA9</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Oldfield</gtr:surname><gtr:orcidId>0000-0001-7423-8378</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BEB1EB0E-5997-4297-935F-BA663369D82E"><gtr:id>BEB1EB0E-5997-4297-935F-BA663369D82E</gtr:id><gtr:firstName>Karl</gtr:firstName><gtr:otherNames>Graham</gtr:otherNames><gtr:surname>Wooldridge</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B54BC0FF-BF65-4FEB-B88F-75495E824BE7"><gtr:id>B54BC0FF-BF65-4FEB-B88F-75495E824BE7</gtr:id><gtr:firstName>Dlawer</gtr:firstName><gtr:surname>Ala'Aldeen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801173"><gtr:id>8DFFF8C6-9EAB-4E2C-B1AB-3D84F616E536</gtr:id><gtr:title>The laminin receptor protein as a target for therapeutics against bacterial meningitis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801173</gtr:grantReference><gtr:abstractText>Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae are the most common causes of bacterial meningitis worldwide. Although these bacteria are sensitive to most antibiotics in current use, and vaccines are available against some strains of these bacteria, they continue to cause high morbidity and mortality in all age groups. Better understanding of the disease process is required before novel preventative and treatment strategies are designed. In recent studies, we identified a key human molecule (laminin receptor, LR) that is involved in mediating bacterial invasion of the blood-brain barrier. We identified LR-binding molecules on each of the three bacterial pathogens and carried out extensive experiments confirming the specificity of the interactions. In this proposal, we plan to study molecular and biological properties of the interaction with the ultimate goal of exploiting the LR-bacterial interaction to develop therapeutic and/or preventative agents that can block bacterial invasion of the blood brain barrier.</gtr:abstractText><gtr:technicalSummary>Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae are the leading bacterial pathogens responsible for pyogenic meningitis and other sepsis syndromes. Despite sensitivity to antibiotics and availability of vaccines against a subset of these bacteria, they remain the major causes of morbidity and mortality worldwide. Better understanding of the host-pathogen interaction at the blood-brain barrier (BBB) is key to the design of novel therapeutic and
preventative strategies. Given the convergent evolution of these
bacteria, we hypothesized that a common molecular interaction might underlie their tropism for the BBB. Using several independent methods, we identified the 37/67-kD laminin receptor (LR) as a common receptor for all three bacteria on host brain vascular endothelial cells. Mutagenesis studies indicated the corresponding LR binding adhesins were pneumococcal CbpA, meningococcal PilQ and PorA, and OmpP2 of H. influenzae. Competitive binding of the bacteria, purified adhesins, LR peptides and antibodies suggested a common LR-carboxyterminal recognition site. The main objectives of this proposal are (i) localising the minimum functional domains on both the LR protein and the LR-binding bacterial adhesins, (ii) elucidating the in vitro and in vivo functional relevance of the identified LR-adhesin interactions, and (iii) understanding LR-mediated early cell signalling events in host cells in response to bacterial ligands, and determining the impact of inhibiting the LR-adhesin interaction and bacterial-host cell interaction. The ultimate goal is to develop therapeutic and/or preventative agents that can block the LR-bacterial adhesin binding domains.</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-12</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-17</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>665147</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Molecular Medical Sciences Nottingham</gtr:department><gtr:description>Laminin receptor-binding proteins in Pseudomonas aeruginosa</gtr:description><gtr:id>4DC63CD9-07FE-446A-BD7A-F2CA7534986B</gtr:id><gtr:impact>None so far.</gtr:impact><gtr:outcomeId>Dv474DBZKBs-1</gtr:outcomeId><gtr:partnerContribution>We have been able to extend our findings relating to mucosal pathogens to the opportunist pathogen Pseudomonas aeruginosa.</gtr:partnerContribution><gtr:piContribution>Development of protocols to identify Laminin receptor-binding bacterial surface proteins.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Umea University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Department of Medical Biochemistry and Biophysics</gtr:department><gtr:description>Laminin receptor binding protein of H. pylori</gtr:description><gtr:id>1ED3DE92-E54B-4ADC-BEA2-1E74E02AE2D6</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>VSy2Z3ANYJP-1</gtr:outcomeId><gtr:partnerContribution>The collaborators have demonstrated that the laminin receptor appears to be a glycoprotein. We are examining the possible role of the glycan structures in the interaction between LR and the bacterial LR-biding proteins that we have identified in various mucosal pathogens, principly Neisseria meningitidis.</gtr:partnerContribution><gtr:piContribution>Protocols developed in our research group, which have facilitated identification of bacterial surface ligands for the human laminin receptor have been utilised to identify an LR-binding surface protein in the mucosal (gastric) pathogen Helicobacter pylori.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Clinical Microbiology Post-Graduate Seminar Series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A7AA499B-7DA9-4B73-8D00-BA4881B3DFBF</gtr:id><gtr:impact>The talk sparked questions and discussion afterwards

Informed Clinical colleagues about on-going work regarding Laminin receptor and Neisseria. Expected to lead to additional collaborations.</gtr:impact><gtr:outcomeId>5460c0b7885543.30659534</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to postgraduate students at Oxford University</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6DB3FC54-2C4D-468C-9AD4-52A46A3B4EB0</gtr:id><gtr:impact>Our work on the laminin receptor and its role in the development of bacterial meningitis was presented to a group of postgraduate students and researchers at Oxford University. The presentation of our data led to many questions and discussions as to possible medical interventions informed by this research.

Scientific discussion</gtr:impact><gtr:outcomeId>faVa6VVaLLQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>76400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC DTG PhD studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/F017154/1</gtr:fundingRef><gtr:id>AD239C6D-5B05-4CD3-808E-0826C4D85817</gtr:id><gtr:outcomeId>McZWTNo4EYA</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SGM Scientific Meetings Travel Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Society of General Microbiology</gtr:fundingOrg><gtr:id>47697A1B-C190-49C5-98DC-80F9ED2E87D2</gtr:id><gtr:outcomeId>g32sUehJzE6</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>ESCMID Travel Grant 2012</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>European Society of Clinical Microbiology and Infectious Diseases (ESCMID)</gtr:fundingOrg><gtr:id>9F9F41EA-2574-4937-B0B4-DE42FD09BFBD</gtr:id><gtr:outcomeId>DRuCBiQLE8j</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>we have constructed a number of vectors for use in mammalian cell transfections that will allow us to express laminin receptor in mammalian cells and to purify the molecule in its native form. This will facilitate a number of lines of enquiry, including the nature of the laminin receptor that interacts with the bacterial ligands that we have identified. This will also contribute to the basic knowledge of the biology of the laminin receptor.</gtr:description><gtr:id>E357FD1E-A7C2-4E64-8A0E-E2A26B688B88</gtr:id><gtr:impact>None as yet, but we envisage that these materials will be invaluble in investigating the nature of the various forms (molecular mass species) that can be detected, as well as investigating their interaction with bacterial cells/adhesins.</gtr:impact><gtr:outcomeId>nJrZu2SC86w</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>tagged laminin receptor-expressing vectors</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>887480AC-5CFD-4765-A6FD-4F9363C0ABB2</gtr:id><gtr:title>Deciphering the complex three-way interaction between the non-integrin laminin receptor, galectin-3 and Neisseria meningitidis.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6068e6273b6ae4bad326ad7cee8540a9"><gtr:id>6068e6273b6ae4bad326ad7cee8540a9</gtr:id><gtr:otherNames>Alqahtani F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>5460be526690f0.40565679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF0074D3-08C2-48F1-9815-91402AE64BCF</gtr:id><gtr:title>Mapping the laminin receptor binding domains of Neisseria meningitidis PorA and Haemophilus influenzae OmpP2.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e36426735e76c412af946860f516978"><gtr:id>5e36426735e76c412af946860f516978</gtr:id><gtr:otherNames>Abouseada NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Ww7Jk4piGo9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801173</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>